Navigation Links
Use of intraoperative MRI adds time but care-changing information to neurosurgery, study shows
Date:11/19/2007

Although the use of intraoperative MRI can add time to surgical procedures, it can help surgeons detect residual disease and, if needed, modify their plan for surgery while the patient is on the operating room table, according to a study conducted by researchers at the University Hospitals of Cleveland/Case Western Reserve University in Cleveland, OH and Johns Hopkins University in Baltimore, MD.

The study included 122 patients between the ages of 6-77 who underwent 130 neurosurgical and ear, nose and throat procedures, including 106 craniotomies and 17 pituitary resections. The study showed that 73% of the patients who had undergone intraoperative MRI had additional surgical resection based on the intraoperative findings, said Jonathan Lewin, MD, lead author of the study. Each patient had between one and five intra-or postoperative imaging sessions which were between 1.7 seconds to 8 minutes. According to the study, the added total imaging time per case was around 35 minutes.

While neurosurgeons and neuroradiologists have been enthusiastic about the potential of intraoperative MRI, no one had investigated the additional time required to add this to a routine neurosurgical case, Dr. Lewin said. With the development of several technological advances geared toward limiting the time required, our goal was to quantitatively measure the impact on surgery from both the time perspective and the benefit of this additional information, he said.

With appropriate technology and workflow design, the benefits of real-time MRI information during surgical procedures can be provided without significant prolongation of the cases, said Dr. Lewin.The neurosurgical physicians have readily adopted the use of intraoperative MRI despite the additional time required, he said.

The full results of this study appear in the November issue of the American Journal of Roentgenology, published by the American Roentgen Ray Society.


'/>"/>

Contact: Necoya Tyson
necoya@arrs.org
703-858-4304
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Informational handout key to giving parents a better understanding of CT radiation risks
2. HIV denialists spread misinformation online -- consequences could be deadly; and more
3. One of the Largest Post-WHI Physician Surveys Shows More Education is Needed: Patient Misinformation About Hormone Therapy Remains High
4. Justice Department to Hold Media Event to Demonstrate New Database for Matching Unidentified Remains and Missing Persons Information
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
6. MEDEX Global Group & Harvard Medical International Join Forces to Create the Most Comprehensive Health Information Resource for International Travelers
7. Cities Say Restaurant Nutrition Information Crucial in Fighting Obesity
8. Metropolitan Hosts Informational Meetings in Nassau County
9. Health IT Now! Coalition Urges Congress to Pass Health Information Technology Bill This Year
10. Unanticipated consequences of health-care information technology
11. Breast cancer survivors optimistic, yet lack critical information on reducing recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...NGE COUNTY, Calif., Nov. 21 Album ...ting firm, launches a new program offering big bra...have taken the large, expensive ad agency process ...s with a very hands-on approach," says Matt Parker... 2002, combines experience and proven brand-buildi...
(Date:11/21/2008)...USTON(Nov. 21, 2008)The University of Texas Health...am, Training Excellence in Aging Studies (TEXAS), ...ugh a prestigious $2 million award from the Donald...ing funds., "This will allow us to teach geriatri...nior medical student to practicing physicians. Wit...
(Date:11/21/2008)... researchers remain cautious about future antibiot...FRIDAY, Nov. 21 (HealthDay News) -- People with mo...ease (COPD) may be able to reduce the frequency of...mmon antibiotic, a new report says. , The stud...e American Journal of Respiratory and Critical Ca...
(Date:11/21/2008)...LADELPHIA, Nov. 21 NursingCenter.c...g education and peer reviewed content, has been,u...ts 350,000 registered,users. Powered by Lippincot...now,provides over 900 peer-reviewed continuing ed...cles from more than 50 leading nursing journals.,...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Long-Term Erythromycin Cut COPD Complications 2Health News:NursingCenter.com Launches New Features to Improve User Experience 2Health News:NursingCenter.com Launches New Features to Improve User Experience 3
...ten years since the Transplantation of Human Organ...adway with the programme. This has been due to var...f direction and the will to seriously consider thi...tion. There has been a lack of initiative from th...
...ording to a study published in the August issue of...troke patients are admitted to and discharged from...nts significantly. Studies have shown that several...e// the amount of disability, complications and th...
...osure to cosmic radiations while flying may increa...s, in comparison to non-pilots. The research was p...es of Ophthalmology. Commercial airline pilots are...or some cancers, but studies on the biological eff...
...ording to a recent study researchers say that they... of prostate tumour cells in laboratory settings. ...nce of prostate cancer // could be due to a rapid ...y acids in the western diet in recent years. Omega...
Other Medicine News:Health News:The Potential Of Cadaver Transplantation Programme In India 2Health News:The Potential Of Cadaver Transplantation Programme In India 3Health News:Simple Procedural Improvements Can Improve Care Of Stroke Patients 2Health News:Airlines Pilot At Heightened Risk Of Having Cataracts, 2
(Date:11/20/2008)...RNewswire/ -- New Jersey American Water has lifte...ustomers in the following municipalities in Middle...esex County , , , Dunellen , ... South Plainfield , , , , Some... Bridgewater , Green Brook , Hill...
(Date:11/20/2008)...PRNewswire-FirstCall/ -- Bionovo, Inc.,(Nasdaq: ... from the Phase 1B,clinical trial of their lead d...er, BZL101, at the Society for Integrative Oncolog...orgia. The Company,s oral presentation was select...d as a part of the Best of the,SIO Session on Nov...
(Date:11/20/2008)...20 The Scandinavian-based drug,de...sults of studies on its,lead antimicrobial candid...,the studies showed that the novel lytic peptidom...ignificantly better towards killing Staphylococcus...gold standard drugs. In,addition to this it has p...
(Date:11/19/2008)...PRNewswire/ -- Biotech scientists increasingly are...arch to better understand the effects of novel dru...s Genetic Engineering & Biotechnology News (... out a new compound,s mechanism of action and even...e, according to the November 15 issue of GEN . ( ...
Breaking Medicine Technology:New Jersey American Water Lifts Precautionary Boil Water Advisory For Middlesex, Somerset and Union Counties 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Existing anti obesity drugs may be effective against flu hepatitis and HIV 26837 1Existing anti obesity drugs may be effective against flu hepatitis and HIV 26837 2Existing anti obesity drugs may be effective against flu hepatitis and HIV 26837 3Existing anti obesity drugs may be effective against flu hepatitis and HIV 26837 4Older Problem Gamblers Face Increased Suicide Risk 26835 1Older Problem Gamblers Face Increased Suicide Risk 26835 2Hearing Officer Secretary Ray Marshall to Set Additional Date 28s 29 for United Healthcare Workers West Trusteeship Hearing 26831 1Hearing Officer Secretary Ray Marshall to Set Additional Date 28s 29 for United Healthcare Workers West Trusteeship Hearing 26831 2Updated MD CARE Act Receives Final Congressional Approval 26827 1Updated MD CARE Act Receives Final Congressional Approval 26827 2
...condary endpoints of,study; no negative drug-drug ...d ribavirin ~, CAMBRIDGE, Mass., June 12, 2007 /PR.... today announced results from a phase II study,de...sisting of,valopicitabine (NM283), Idenix,s lead d...gylated interferon and ribavirin,compared to pegyl...
...2007 - Geron,Corporation,s (Nasdaq:GERN) telomeras... good pharmacokinetics and tolerability in,its ong...nic,lymphocytic leukemia (CLL), according to data ...e company,s president, oncology, at,the Pan Pacifi...Pharmacokinetics; Pharmacodynamics Consistent with...
Other Medicine Technology:Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 2Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 3Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 4Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 5Valopicitabine Combined with Standard of Care Cleared Hepatitis C,Virus in 72% of Patients Who Completed 12 Weeks of Treatment in a,Phase II Trial 6Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 2Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 3Geron's Telomerase Inhibitor Cancer Drug Demonstrates Good,Pharmacokinetics and Tolerability in Phase I/II Trial 4
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Bulb Direct has been selling replacement bulbs on the Internet since 1996, and we are extremely proud of our 100% satisfaction guarantee. Check out our catalog of replacement bulbs and see our discou
Medicine Products: